Trump floats 25% tariffs on US car, drug, chip imports
Overnight comments are most detailed yet in specifying other sectors to be hit and would mark a dramatic widening of trade war
Overnight comments are most detailed yet in specifying other sectors to be hit and would mark a dramatic widening of trade war
Continent’s top firms drove most of European equity gains last year
Euronext Dublin finished the day down 0.3% as it was dragged lower by homebuilders and hotels group Dalata
British drug maker’s first annual earnings report after spinning off Haleon in July 2022
Pharma giant GSK, whose predecessor companies profited from the trials, has so far resisted calls to contribute
British medicines group and US rival Pfizer have both committed to selling down stakes over time to fund core pharma operations
Shoppers choosing to buy less has spooked large groups but costs unlikely to drop even as inflation moderates
Maker of Marmite and Magnums latest to signal easing of inflationary pressures
Bank shares edge backwards while Glanbia and Irish Continental rise
Drugmaker’s Xevudy fails to tackle most prevalent variants of coronavirus, say US regulators
Kate Ferry to replace Julie Brown who heads to GSK
Drug giant rang up worldwide sales of more than £29 billion last year. Its refusal to contribute a cent to State’s redress scheme is inexcusable
Questions remain about hospitalisation and side effects but drugmaker stays step ahead of British group GSK which faces similar panel
In the News podcast with Bernice Harrison
Clinical trials carried out between 1934 and 1973 centred on childhood vaccines and infant milk products
O’Gorman urged drug firm to accept corporate responsibility for way tests were carried out on mother-and-baby home children
UK drugmaker counting on several new vaccines, including one against RSV, to power growth in 2023
Chief commercial officer Luke Miels looking at targets, especially in cancer therapies, worth up to $2.5bn
Pharmaceutical companies hunt for new revenue streams as pandemic becomes endemic
Rump business will focus solely on vaccines and prescription medications
Sanofi says trials point to potential of its vaccine booster candidate against main variants of concern
Company is planning to separate its consumer unit
Iseq in Dublin closes the session up 1.3%
Building and travel stocks struggle on Iseq
Twitter stock tanks after Elon Musk puts $44bn deal on hold, but Tesla stock rises
Bargain-hunters enter market after sell-off on economic worries
Iseq down 0.5% as travel and leisure names weaken
British drugmaker confirms guidance for year in which it will spin-off its consumer goods division
Strike backed by 86% of those balloted on below inflation pay offer would be first for top drugmaker
Crosswords & puzzles to keep you challenged and entertained
Get the latest news, analysis and match reports from the M6N and W6N championships
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices